A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes

Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes ind...

Full description

Bibliographic Details
Main Authors: Snehaa V. Seal, Mathilde Henry, Clémentine Pajot, Cyrielle Holuka, Danielle Bailbé, Jamileh Movassat, Muriel Darnaudéry, Jonathan D. Turner
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.896179/full
_version_ 1828332361386819584
author Snehaa V. Seal
Snehaa V. Seal
Mathilde Henry
Clémentine Pajot
Cyrielle Holuka
Cyrielle Holuka
Danielle Bailbé
Jamileh Movassat
Muriel Darnaudéry
Jonathan D. Turner
author_facet Snehaa V. Seal
Snehaa V. Seal
Mathilde Henry
Clémentine Pajot
Cyrielle Holuka
Cyrielle Holuka
Danielle Bailbé
Jamileh Movassat
Muriel Darnaudéry
Jonathan D. Turner
author_sort Snehaa V. Seal
collection DOAJ
description Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats.
first_indexed 2024-04-13T21:04:02Z
format Article
id doaj.art-b5db86067215415687966f5d0b7fcb70
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T21:04:02Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b5db86067215415687966f5d0b7fcb702022-12-22T02:30:03ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-05-011310.3389/fimmu.2022.896179896179A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 DiabetesSnehaa V. Seal0Snehaa V. Seal1Mathilde Henry2Clémentine Pajot3Cyrielle Holuka4Cyrielle Holuka5Danielle Bailbé6Jamileh Movassat7Muriel Darnaudéry8Jonathan D. Turner9Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, LuxembourgFaculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, LuxembourgInstitut National de Recherche Pour l'agriculture, l'alimentation et l'environnement (INRAE), Bordeaux Institut National Polytechnique (INP), NutriNeuro, Unité Mixte de Recherche (UMR) 1286, University of Bordeaux, Bordeaux, FranceInstitut National de Recherche Pour l'agriculture, l'alimentation et l'environnement (INRAE), Bordeaux Institut National Polytechnique (INP), NutriNeuro, Unité Mixte de Recherche (UMR) 1286, University of Bordeaux, Bordeaux, FranceDepartment of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, LuxembourgFaculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, LuxembourgUniversité de Paris, Laboratoire B2PE (Biologie et Pathologie du Pancréas Endocrine), Unité BFA (Biologie Fonctionnelle et Adaptative), Centre National de la Recherche Scientifique -Unité Mixte de Recherche (CNRS UMR) 8251, Paris, FranceUniversité de Paris, Laboratoire B2PE (Biologie et Pathologie du Pancréas Endocrine), Unité BFA (Biologie Fonctionnelle et Adaptative), Centre National de la Recherche Scientifique -Unité Mixte de Recherche (CNRS UMR) 8251, Paris, FranceInstitut National de Recherche Pour l'agriculture, l'alimentation et l'environnement (INRAE), Bordeaux Institut National Polytechnique (INP), NutriNeuro, Unité Mixte de Recherche (UMR) 1286, University of Bordeaux, Bordeaux, FranceDepartment of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, LuxembourgType-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats.https://www.frontiersin.org/articles/10.3389/fimmu.2022.896179/fulldiabetesobesitycytokinesinflammationmicroarraysGoto-Kakizaki rats
spellingShingle Snehaa V. Seal
Snehaa V. Seal
Mathilde Henry
Clémentine Pajot
Cyrielle Holuka
Cyrielle Holuka
Danielle Bailbé
Jamileh Movassat
Muriel Darnaudéry
Jonathan D. Turner
A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
Frontiers in Immunology
diabetes
obesity
cytokines
inflammation
microarrays
Goto-Kakizaki rats
title A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_full A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_fullStr A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_full_unstemmed A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_short A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_sort holistic view of the goto kakizaki rat immune system decreased circulating immune markers in non obese type 2 diabetes
topic diabetes
obesity
cytokines
inflammation
microarrays
Goto-Kakizaki rats
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.896179/full
work_keys_str_mv AT snehaavseal aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT snehaavseal aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT mathildehenry aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT clementinepajot aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT cyrielleholuka aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT cyrielleholuka aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT daniellebailbe aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT jamilehmovassat aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT murieldarnaudery aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT jonathandturner aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT snehaavseal holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT snehaavseal holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT mathildehenry holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT clementinepajot holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT cyrielleholuka holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT cyrielleholuka holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT daniellebailbe holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT jamilehmovassat holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT murieldarnaudery holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT jonathandturner holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes